ABOUT EXCELLOS
As a strategically focused CDMO, Excellos combines the best of both worlds: the tailored, consultative support of a boutique firm with the scientific and operational strength needed to support complex, high-stakes programs. We offer bespoke solutions across the full development lifecycle, from donor-sourced starting material to final product characterization. Our model is intentionally focused: we’re structured to move quickly, collaborate deeply, and adapt to your unique needs without compromising quality or scalability. With a foundation rooted in clinical experience, a close partnership with the San Diego Blood Bank, and a culture of scientific rigor, Excellos brings both precision and flexibility to every engagement — helping our partners accelerate progress with confidence.
INDUSTRY INSIGHTS
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "3 Key Bottlenecks In Cell Therapy Supply Chains")
Ensure your cell therapy program is prepared for the future by learning how to effectively navigate sourcing, logistics, and manufacturing challenges with confidence.
-
![GettyImages-879689410 blood]( "Choosing The Right PBMCS For Your Research And Product Development Needs")
Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.
-
![GettyImages-155278566-cryopreservation]( "Ensuring Reliability And Patient Safety With XiltriX")
Protect the integrity of your therapies and ensure patient safety by investing in reliable, real-time environmental monitoring systems that proactively address operational vulnerabilities.
-
![Sales Team]( "Spotlight On Excell-Ence: Project Management Team")
Discover the difference a dedicated, expert project management team can make in ensuring the success and smooth execution of your cell therapy programs.
-
![Field Service Partner Management]( "Proud To Be Part Of Arm: Advancing The Future Of Regenerative Medicine Together")
With hundreds of members spanning over 25 countries, ARM serves as a hub for innovation, policy development, and cross-sector collaboration in regenerative medicine.
-
![GettyImages-1288118586 cell development]( "Development Of Endothelial-Cord Cell Banks And Blood Stem Cell Products")
Leverage our proven cGMP expertise in cell therapy manufacturing, from primary tissue processing to large-scale production for clinical trials.
-
![GettyImages-151617200-petri dish-bacteria-cells]( "Confirming Feeder Cells For TIL Expansion")
To ensure the safety of tumor-infiltrating leukocytes (TIL) therapies, it's important to use cGMP-compliant feeder cells confirmed to be non-proliferative through competency testing.
-
![Meet The Team]( "Spotlight On Excell-Ence: Quality Assurance Team")
A QA team at a cell therapy CDMO ensures all aspects of development and manufacturing meet the highest standards of quality, safety, and regulatory compliance.
CONTACT INFORMATION
Excellos
1155 Island Ave, Suite 400
San Diego, CA 92101
UNITED STATES
Phone: (619) 496-7001
Contact: Jessica Wanamaker, VP of Business Development
SOLUTIONS
-
![GettyImages-1339300422 CAR T-Cell Immunotherapy]( "Immunotherapy Development")
Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.
-
![GettyImages-1163687229-cells-CAR-T-human]( "Allogeneic CAR-T Cells")
Allogeneic CAR-T Cells Vs Autologous
Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.
-
![GettyImages-2173307727-scientist-gloves-cell-culture-assay-pipette]( "Cell Therapy Services: Customized Cell Collections")
Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.
-
![GettyImages-1284610189-laboratory-research-development-cell-culture]( "Cell Therapy Services: Process Development And cGMP Manufacturing")
Now that you have the best donated cellular material, it is time to optimize your cell therapy process for cGMP manufacturing. We offer R&D services including process development and cGMP production for Phase I through Commercial manufacturing.
